Clearance evidence

Peptide

ATLPC0006669

Measured material

Specific molecular form

Endpoint

Clearance

ADMET domain

Excretion / Persistence

Value

Observation

Total plasma clearance (CL T ), elimination half-life (t 1/2 ), and volume of distribution at steady-state (V ss ) in patients with cSSSI were similar to those in patients with S. aureus bacteremia.

Evidence role

Reported: reviewed reported observation that should not be pooled as a comparable value yet

Assay / model

human · plasma

Condition

Daptomycin · 1957b6ce-7382-4a7b-bf02-3595948d09c6 · 12.3 Pharmacokinetics · daptomycin infection context clearance vss similarity text · Total plasma clearance (CL T ), eliminatio...

Scientific source

DailyMed

Open source

Clearance evidence

Developability

Resources

Measurement